A multi-disciplinary team of scientists
TEAM MEMBERS
A multidisciplinary team of scientists
United by the goal of transforming preventive medicine through molecular health monitoring.
Prof. Dr. Ferenc Krausz
Nobel Laureate in Physics (2023) and pioneer of attosecond science. Directs the Attoworld group at MPI for Quantum Optics and LMU Munich, where his team developed electric-field molecular fingerprinting for blood-based disease detection.
Founder
Dr. Raphael Tautz, LL.M.
Focuses on corporate governance, strategic partnerships and organizational development. He brings legal expertise and experience at the intersection of medical diagnostics, deep technology and international collaboration.
Interim CEO and Managing Director
Dr. Marija Marolt
Oversees clinical study design and study protocols across all partner centers. Brings extensive experience in translational research and clinical trial management to the initiative's multi-site coordination.
Chief Clinical Officer
Leads the scientific integration of molecular fingerprinting platforms and AI-driven analysis pipelines. Brings expertise in translational molecular medicine to the initiative's research architecture and data strategy.
Chief Scientific Officer
Dr. Min Kim
Dr. Kosmas Kepesides
Leads machine learning development and multi-omics data integration for PH1.0 algorithm development. Specialises in high-dimensional biological data, longitudinal modelling, and computational health science.
Chief Data Scientist
Prof. Dr. Julia Yamnenko
Coordinates multi-institutional collaboration, deliverables, and timeline management across the global partner network. Background in clinical research operations and international scientific project management.
Project Manager
Markó Madaras
Chief Financial Advisor
Senior management professional with extensive experience in financial and operational management across research-driven and public-interest organizations. Advises on financial planning, governance, compliance, organizational development, and complex public and private funding.
Prof. Dr. Zoltán Takáts
Inventor of rapid evaporative ionization mass spectrometry (REIMS) and a world leader in metabolomics and lipidomics. Advises on mass spectrometry-based profiling strategy and analytical pipeline design.
Chief Scientific Advisor
Dr. Domokos Gerő
Senior clinician with expertise in genomics and metabolic disease. Advises on clinical endpoints, participant stratification, and the translation of molecular signals into actionable clinical protocols.
Chief Clinical Advisor